Shaanxi Huifeng Pharmaceutical Ltd. is a growing manufacturer and supplier of high quality plant extracts and raw materials used in the production of pharmaceuticals, nutraceuticals and food in the People's Republic of China (PRC). Founded in 2000,Located in the cities of Xi'an and Xianyang in China, The Company is a leading Chinese producer and exporter of Rutin and Rutin-related plant derived flavonoids, as well as a significant producer of Diosmin, both of which have powerful antioxidant and medicinal properties and are used as ingredients in therapies that target venous diseases, inflammation, and dermatitis among other chronic health issues. The Company's products have multiple end markets, including pharmaceuticals, nutraceuticals, cosmetics, foods and beverages.
The Company is the leading Chinese producer and exporter of both Rutin and Diosmin, with approximately 40% of the Diosmin and 8% of the Rutin market in China. Currently only Brazil, Vietnam and China produce Rutin and only Huifeng holds a patent in China for one of the most efficient Rutin and Diosmin production methods. In addition, Huifeng is the first CEP-approved Chinese vendor of Diosmin.
Rutin and Diosmin, are used as ingredients in therapies that target venous diseases, inflammation, and dermatitis among other chronic health issues. Diosmin has been used for more than 30 years as an oral phlebotonic drug and vascular-protecting agent as well as for hemorrhoidal disease, and has recently begun to be investigated for other therapeutic purposes, including cancer, premenstrual syndrome, colitis, and diabetes.
The Company has a diverse client base, which includes customers in China, Spain, France,Poland, Germany, Russia, India, and the United States. Huifeng has been able to establish strategic relationships with its customers, entering into long-term supply agreements that are generally in excess of two years.
Huifeng's products and manufacturing practices have continually met international quality standards. The Company received an ISO 9001:2008 certification for all of its manufacturing facilities. In 2010, its Good Manufacturing Practices (GMP) certificate was renewed, a qualification that enables it to sell its products without restriction in China. The Company has also received the COS (European Certificate of Suitability) certification for Diosmin in 2011. Huifeng is the first Chinese producer of Diosmin able to expand in Europe, which should allow the Company to significantly expand its customer base and increase revenues.
Huifeng is diversifying its product lines internally, through acquisitions, and through cooperation with leading scientific research organizations. The Company has developed proprietary processes to manufacture Rutin and Diosmin efficiently while ensuring the highest product quality. Huifeng has focused its efforts on developing new technologies and products and continues to invest heavily in R&D in order to remain competitive.
The Company is the leading Chinese producer and exporter of both Rutin and Diosmin, with approximately 40% of the Diosmin and 8% of the Rutin market in China. Currently only Brazil, Vietnam and China produce Rutin and only Huifeng holds a patent in China for one of the most efficient Rutin and Diosmin production methods. In addition, Huifeng is the first CEP-approved Chinese vendor of Diosmin.
Rutin and Diosmin, are used as ingredients in therapies that target venous diseases, inflammation, and dermatitis among other chronic health issues. Diosmin has been used for more than 30 years as an oral phlebotonic drug and vascular-protecting agent as well as for hemorrhoidal disease, and has recently begun to be investigated for other therapeutic purposes, including cancer, premenstrual syndrome, colitis, and diabetes.
The Company has a diverse client base, which includes customers in China, Spain, France,Poland, Germany, Russia, India, and the United States. Huifeng has been able to establish strategic relationships with its customers, entering into long-term supply agreements that are generally in excess of two years.
Huifeng's products and manufacturing practices have continually met international quality standards. The Company received an ISO 9001:2008 certification for all of its manufacturing facilities. In 2010, its Good Manufacturing Practices (GMP) certificate was renewed, a qualification that enables it to sell its products without restriction in China. The Company has also received the COS (European Certificate of Suitability) certification for Diosmin in 2011. Huifeng is the first Chinese producer of Diosmin able to expand in Europe, which should allow the Company to significantly expand its customer base and increase revenues.
Huifeng is diversifying its product lines internally, through acquisitions, and through cooperation with leading scientific research organizations. The Company has developed proprietary processes to manufacture Rutin and Diosmin efficiently while ensuring the highest product quality. Huifeng has focused its efforts on developing new technologies and products and continues to invest heavily in R&D in order to remain competitive.
